Aehr Test Systems (NASDAQ:AEHR – Get Free Report) CEO Gayn Erickson sold 40,000 shares of the stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $130.84, for a total value of $5,233,600.00. Following the sale, the chief executive officer owned 157,723 shares in the company, valued at approximately $20,636,477.32. This trade represents a 20.23% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.
Aehr Test Systems Trading Up 8.7%
NASDAQ:AEHR opened at $134.06 on Friday. Aehr Test Systems has a 12-month low of $16.38 and a 12-month high of $147.40. The firm has a market cap of $4.37 billion, a price-to-earnings ratio of -558.56 and a beta of 3.10. The company’s 50-day moving average is $92.83 and its two-hundred day moving average is $71.45.
Key Aehr Test Systems News
Here are the key news stories impacting Aehr Test Systems this week:
- Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
- Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
- Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
- Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
- Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
- Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation
Analyst Upgrades and Downgrades
Get Our Latest Stock Report on AEHR
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in AEHR. BlackRock Inc. acquired a new stake in Aehr Test Systems during the 2nd quarter valued at $255,476,000. Vanguard Group Inc. lifted its holdings in Aehr Test Systems by 2.2% in the 4th quarter. Vanguard Group Inc. now owns 2,337,433 shares of the semiconductor company’s stock worth $47,193,000 after buying an additional 49,243 shares in the last quarter. Wellington Management Group LLP lifted its holdings in Aehr Test Systems by 129.9% in the 4th quarter. Wellington Management Group LLP now owns 830,664 shares of the semiconductor company’s stock worth $16,771,000 after buying an additional 469,400 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Aehr Test Systems by 0.8% in the 4th quarter. Geode Capital Management LLC now owns 685,694 shares of the semiconductor company’s stock worth $13,846,000 after buying an additional 5,591 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new position in Aehr Test Systems in the 2nd quarter valued at about $64,433,000. 69.69% of the stock is owned by institutional investors and hedge funds.
Aehr Test Systems Company Profile
Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.
The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.
Further Reading
- Five stocks we like better than Aehr Test Systems
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.
